Skip to main content
argenx SE (ARGNF)
OTCMKTS · Delayed Price · Currency is USD
547.60
+0.42 (0.08%)
At close: Jul 2, 2025

argenx SE Revenue

argenx SE had revenue of $967.19M in the quarter ending June 30, 2025, with 97.62% growth. This brings the company's revenue in the last twelve months to $3.12B, up 88.04% year-over-year. In the year 2024, argenx SE had annual revenue of $2.25B with 77.22% growth.

Revenue (ttm)
3.12B
Revenue Growth
+88.04%
P/S Ratio
12.65
Revenue / Employee
1.95M
Employees
1,599
Market Cap
39.49B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.25B979.61M77.22%
Dec 31, 20231.27B827.58M187.66%
Dec 31, 2022441.01M-87.25M-16.52%
Dec 31, 2021528.27M466.31M752.59%
Dec 31, 202061.96M-30.85M-33.24%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Veradigm 588.02M
Tian'an Technology Group 1.78M
Elite Pharmaceuticals 84.04M
Glass House Brands 215.62M
Northwest Biotherapeutics 1.47M
American Oncology Network 1.76B
Silence Therapeutics 27.17M
Global Cord Blood 196.10M
Revenue Rankings

argenx SE News

More News